New eye drop shows promise for pink eye in early trial
Disease control
Completed
This study tested a new eye drop called SCH1 for treating acute infectious conjunctivitis (pink eye). Thirty adults with pink eye symptoms for less than 72 hours received either the eye drop or a placebo. The goal was to see if the drops could completely clear redness and dischar…
Phase: PHASE2 • Sponsor: Sacsh • Aim: Disease control
Last updated May 15, 2026 11:57 UTC